These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1248638)

  • 21. A rare case of a compound heterozygote hemoglobin S/hemoglobin Fannin-Lubbock-I individual. Is it a sickling disorder?
    Burns NK; Risin SA
    Lab Hematol; 2010 Jun; 16(2):26-7. PubMed ID: 20534428
    [No Abstract]   [Full Text] [Related]  

  • 22. Sickle cell hemoglobin: molecular basis of sickling phenomenon theory and therapy.
    Murayama M
    CRC Crit Rev Biochem; 1973 Sep; 1(4):461-99. PubMed ID: 4594860
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of sickling in deer erythrocytes.
    Amma EL; Sproul GD; Wong S; Huisman TH
    Ann N Y Acad Sci; 1974 Nov; 241(0):605-13. PubMed ID: 4530684
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the water environments in deoxygenated sickle cells by longitudinal and transverse water proton relaxation rates.
    Thompson BC; Waterman MR; Cottam GL
    Arch Biochem Biophys; 1975 Jan; 166(1):193-200. PubMed ID: 1122135
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
    Abraham EC; Stallings M; Abraham A; Garbutt GJ
    Biochim Biophys Acta; 1982 Jul; 705(1):76-81. PubMed ID: 7115734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Delay time of gelation: a possible determinant of clinical severity in sickle cell disease.
    Eaton WA; Hofrichter J; Ross PD
    Blood; 1976 Apr; 47(4):621-7. PubMed ID: 1260125
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemoglobin sickle-lepore: an unusual case of sickle cell disease.
    Romana M; Diara JP; Merghoub T; Kéclard L; Saint-Martin C; Berchel C; Mérault G
    Acta Haematol; 1997; 98(3):170-1. PubMed ID: 9352751
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of phenothiazines on the sickling phenomenon in vitro.
    McFadzean JA; Pugh IM; Squires SL
    Br J Haematol; 1969; 16(1):173-80. PubMed ID: 4893926
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular aspects of tactoid formation in man and animals.
    Murayama M
    Ann N Y Acad Sci; 1974 Nov; 241(0):623-37. PubMed ID: 4530686
    [No Abstract]   [Full Text] [Related]  

  • 32. [Stanleyville II, a variant of the abnormal alpha-chain hemoglobin frequent in the north of Zaire. Apropos of a case of sickle cell anemia with S and Stanleyville II/S hemoglobins].
    Van Ros G
    Ann Soc Belg Med Trop; 1974; 54(6):483-501. PubMed ID: 4469969
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemoglobin interaction: modification of solid phase composition in the sickling phenomenon.
    Bertles JF; Rabinowitz R; Döbler J
    Science; 1970 Jul; 169(3943):375-7. PubMed ID: 5450369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of copper in sickling erythrocytes.
    Schaeffer K; Lofton JA; Powell SC; Osborne HH; Foster LH
    Proc Soc Exp Biol Med; 1968 Jul; 128(3):734-7. PubMed ID: 5668118
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of beta 73 Asn on the interactions of sickling hemoglobins.
    Bookchin RM; Nagel RL; Ranney HM
    Biochim Biophys Acta; 1970 Nov; 221(2):373-5. PubMed ID: 5490239
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions between human hemoglobins: sickling and related phenomena.
    Bookchin RM; Nagel RL
    Semin Hematol; 1974 Oct; 11(4):577-95. PubMed ID: 4608956
    [No Abstract]   [Full Text] [Related]  

  • 37. Lead screening in sickle cell disease.
    Tigner-Weekes L; Pegelow C; Lee S; Powars D
    J Pediatr; 1979 Nov; 95(5 Pt 1):738-40. PubMed ID: 490241
    [No Abstract]   [Full Text] [Related]  

  • 38. Structure of sickle cell hemoglobin and molecular mechanism of the sickling phenomenon.
    Murayama M
    Clin Chem; 1967 Jul; 13(7):578-88. PubMed ID: 4952917
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanical stability of hemoglobin subunits: an abnormality in betaS-subunits of sickle hemoglobin.
    Asakura T; Adachi K; Sono M; Friedman S; Schwartz E
    Biochem Biophys Res Commun; 1974 Apr; 57(3):780-6. PubMed ID: 4827832
    [No Abstract]   [Full Text] [Related]  

  • 40. RATE OF SICKLING OF RED CELLS DURING DEOXYGENATION OF BLOOD FROM PERSONS WITH VARIOUS SICKLING DISORDERS.
    CHARACHE S; CONLEY CL
    Blood; 1964 Jul; 24():25-48. PubMed ID: 14194270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.